Dr Lal Pathlabs Ltd

Small Cap

Healthcare Sector

reflects a positive outlook for the share price

reflects a neutral outlook for the share price

reflects a negative outlook for the share price

The analysts information is for reference only and does not\n  represents an investment recommendation.

Analyst recommendation reflect the views of analysts who follow and write research reports.

Company Information is an introduction to the company’s business that details what it sell, how it was founded, what their mission is, how they manufacture or source their products, and why they serve customers.

Dr. Lal PathLabs has pioneered the use of an AI module for detecting lymph node metastasis in cancer, enhancing diagnostic accuracy. Following this innovation, shares rose by 3.2%.

Dr. Lal PathLabs Adopts AI for Cancer Diagnostics - 20 Aug, 2025

Dr Lal Pathlabs has announced an interim dividend of ₹6 per equity share for the fiscal year 2025-2026, with a record date of August 06, 2025.

Dr Lal Pathlabs Declares Interim Dividend for 2025-2026 - 06 Aug, 2025

Dr Lal PathLabs shows strong financial performance with a 24% rise in net profit and 11.28% increase in net sales for June 2025. Technical indicators suggest bullish momentum, while the CEO outlines growth strategies for fiscal 2026.

Dr Lal PathLabs Reports Strong Growth and Bullish Outlook - 01 Aug, 2025

Dr. Lal PathLabs announced a 24% increase in net profit for June 2025, with net sales rising 19.87%. The Board recommended an interim dividend of Rs 6 per share, subject to shareholder approval.

Dr. Lal PathLabs Reports Strong Earnings and Dividend - 31 Jul, 2025

Dr. Lal Pathlabs, India's largest diagnostics provider, reported a consolidated revenue of ₹24.61 billion and a net profit of ₹4.87 billion for the year ending March, reflecting over 11% growth. The company continues to innovate and expand its services.

Dr. Lal Pathlabs Reports Strong Financial Performance - 25 Jul, 2025

Price to Earnings Ratio or Price to Earnings Multiple is the ratio of the share price of a stock to its earnings per share (EPS). It provides an indication of whether a stock at its current market price is expensive or cheap.

The price/earnings-to-growth ratio, or the PEG ratio, is a metric that helps investors value a stock by taking into account a company's market price, its earnings, and its future growth prospects.

Enterprise value (EV) is the total value of a company, defined in terms of its financing. It includes both the current share price (market capitalization) and the cost to pay off debt (net debt, or debt minus cash).

Alpha measures the amount that the investment has returned in comparison to the market index or other broad benchmark that it is compared against.

Beta measures a stock's volatility, the degree to which its price fluctuates in relation to the overall stock market. In other words, it gives a sense of the stock's risk compared to that of the greater market.

Dividend yield measures the quantum of earnings by way of total dividends that investors make by investing in that company.

The debt-to-total-assets ratio shows how much of a business is owned by creditors (people it has borrowed money from) compared with how much of the company's assets are owned by shareholders.

Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations.

This widget shows the information about the stock's peers in consideration along with the different data for those peers so that the user can compare the stock with the other similar stock and invest accordingly.

Promoter holding is the amount of share of the company that is owned by the promoters. The promoters are the company's founders, who hold a majority stake in the company's capital.

A foreign institutional investor (FII) is an investor or investment fund investing in a country outside of the one in which it is registered or headquartered.

A mutual fund is a pool of money managed by a professional Fund Manager. It is a trust that collects money from a number of investors who share a common investment objective and invests the same in equities, bonds, money market instruments, and other securities.

Retail investors execute their trades through traditional or online brokerage firms or other types of investment accounts. Retail investors purchase securities for their own personal accounts and often trade in dramatically smaller amounts as compared to institutional investors.

This widget shows the bifurcation of stocks based on the percentage of stake with the different types of shareholders.

This widget will help value the stock based on the Price to Earning ratio of the stock and compare the valuation with the industry value and other similar stocks. It even shows the timeline of the valuation of the stock and its highest and lowest valuation over time.
A Time Series data is provided which compares the historical stock PE with Industry PE over the period of 5 years.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

Mutual Funds have increased holdings from 12.84% to 15.04% in Jun 2025 quarter

This section gives you an insight into how the Mutual Funds Holding has changed for the stock over last few quarters.

MF Holding Up

Retail Investor have increased holdings from 5.84% to 6.23% in Jun 2025 quarter

This section gives you an insight into how the Retail Investors Holding has changed for the stock over last few quarters.

Retail Holding Up

Revenue is up for the last 3 quarters, 621.8 Cr → 697.9 Cr (in ₹), with an average increase of 5.5% per quarter

This section gives you an insight into how the revenue of the company has moved for the last few quarters.

Revenue Rich

In the last 3 months, LALPATHLAB stock has moved up by 16.2%

This section gives you an insight into the price movement of the stock for the last few quarters.

Price Rise

In the last 3 years, Fortis Healthcare Ltd has given 230.9% return, outperforming this stock by 190.8%

This section gives you an insight into how the peers have performed as compared to this company in the last 3 years.

Against Peers

In the last 1 year, Fortis Healthcare Ltd has given 69.3% return, outperforming this stock by 71.8%

This section gives you an insight into how the peers have performed as compared to this company in the last 1 year.

Foreign Institutions have decreased holdings from 23.91% to 21.68% in Jun 2025 quarter

This section gives you an insight into how the FII Holding has changed for the stock over last few quarters.

FII Holding Down

Promoters have decreased holdings from 53.91% to 53.79% in Jun 2025 quarter

This section gives you an insight into how the Promoter Holding has changed for the stock over the last few quarters.

Promoter Holding Down

Netprofit is down for the last 2 quarters, 154.8 Cr → 132.4 Cr (in ₹), with an average decrease of 14.5% per quarter

This section gives you an insight into how the profit for the company has been for the last few quarters.

Profit Down

Nifty Smallcap 50

Nifty Small 100

S&P BSE 400 MidSmallCap

BSE 500

S&P BSE 250 SmallCap

Nifty MidSmallcap 400

Nifty Smallcap 250

S&P BSE SmallCap Select

BSE Healthcare

BSE Small-Cap

Nifty 500

HDFC Flexi Cap Fund -Direct Plan - Growth Option

UTI Flexi Cap Fund - Growth Option - Direct

Aditya Birla Sun Life Flexi Cap Fund Direct Plan Growth

Nippon India Pharma Fund - Direct Plan - Growth Plan

SBI Large & Midcap Fund Direct Growth

Dr Lal Pathlabs Ltd’s net profit jumped 24.44% since last year same period to ₹132.40Cr in the Q1 2025-2026. On a quarterly growth basis, Dr Lal Pathlabs Ltd has generated -14.47% fall in its net profits since last 3-months.

Name	Value	Action
MACD level (12,26)	0.56	Bullish
CCI (20)	666.67	Bearish
RSI (14)	60.12	Neutral
Momentum (10)	2.3	Bullish
ADI (14)	13.23	Neutral
Ultimate Oscillator (7,14,28)	25.44	Bearish

Name	Value	Action
SMA (20)	3249.71	Bullish
EMA (20)	3249.86	Bullish
VWMA (20)	3250.13	Bullish
SMA (50)	3249.13	Bullish
EMA (50)	3249.67	Bullish
SMA (200)	3269.42	Bearish
EMA (200)	3268.89	Bearish
KAMA (200)	3251.45	Bullish
DEMA (200)	3238.67	Bullish

Dr Lal Pathlabs Ltd (LALPATHLAB)

Summary

Overall

Oscillators

Moving Averages